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The CBP protein is a transcriptional co-activator and histone acetyltransferase. Reduced expression of Drosophila CBP (dCBP) in the early
embryo specifically impairs signaling by the TGF-β molecules Dpp and Screw (Scw). This occurs by a failure to activate transcription of the
tolloid (tld) gene, which codes for a protease that generates active Dpp and Scw ligands. We show that dCBP directly regulates this gene by
binding to the tld enhancer, and that tld expression can be partially rescued with a dCBP transgene. At a slightly later stage of development, Dpp/
Scw signaling recovers in mutant embryos, but is unable to turn on expression of the Dpp/Scw-target gene rhomboid (rho). Interestingly, an
acetyltransferase (AT)-defective dCBP transgene rescued tld and rho gene expression to an extent comparable to the wild-type transgene, whereas
a transgene containing a 130 amino acid deletion rescued tld but not late rho expression. A tracheal phenotype caused by the reduced dCBP levels
was also rescued more efficiently with the wild-type dCBP transgene than with this mutant transgene. Our results indicate that separate parts of the
dCBP protein are required on different promoters, and that the AT activity of dCBP is dispensable for certain aspects of Dpp signaling. We discuss
the similarity of these results to the role of p300/CBP in TGF-β signaling in the mouse.
© 2007 Elsevier Inc. All rights reserved.Keywords: Transcriptional control; Histone acetylation; TGF-beta signaling; Drosophla embryo developmentIntroduction
The CREB binding protein (CBP) is a transcriptional co-
activator that is conserved in metazoans, but absent from yeast.
In mammals it shares functions with the highly homologous
adenovirus E1A binding protein p300, whereas Drosophila and
Caenorhabditis elegans only contain one CBP ortholog. CBP
and p300 play important roles in embryo development, cell
differentiation, and disease (Goodman and Smolik, 2000). They
act as co-activators by bridging interactions between DNA-
binding transcription factors and the basal transcription
machinery and by affecting the access of factors to DNA
through their intrinsic acetyltransferase (AT) activity (Kalkho-
ven, 2004).⁎ Corresponding author. Fax: +46 8 6126127.
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doi:10.1016/j.ydbio.2007.01.036The size of CBP is about 300 kDa and it has several domains
important for its function. It consists of three cysteine-histidine
(CH)-rich regions, a bromodomain and the AT domain.
Transcriptional activation domains are present in the N-terminus
and in the glutamine-rich C-terminus. In vitro, CBP can interact
with over 40 different transcription factors (Goodman and
Smolik, 2000). Protein–protein interaction domains include
CH1, CH3, and the KIX domain (a schematic outline of CBP is
presented in Fig. 2A). Histone acetylation mediated by these
proteins occurs on multiple lysines in vitro (Schiltz et al., 1999),
but CBP appears to prefer histone H4 lysine 12 (H4K12)
whereas p300 preferentially acetylates H4K8 in vivo (McManus
and Hendzel, 2003). In CBP mutant Drosophila embryos
acetylation of H4K8 and H4K12 is diminished (Ludlam et al.,
2002). CBP also acetylates a number of transcription factors and
thereby changes their activity (Yang, 2004).
We set out to examine whether the transcriptional co-
activator function of CBP involves the AT activity or if it
involves other parts of the protein. A number of in vitro and
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question. The result appears to be context and promoter
dependent. In vivo, CBP AT activity is important for many
processes. Some patients with Rubinstein–Taybi syndrome
contain mutations in CBP that abolish the in vitro HAT activity
of the protein (Kalkhoven et al., 2003; Murata et al., 2001),
indicating a developmental requirement for AT activity. In
mouse, knock-ins of AT-defective p300 or CBP alleles cause
dominant embryonic or neonatal lethality (Shikama et al.,
2003), and expression of an AT-defective CBP transgene in the
mouse forebrain causes a long-term memory deficit while short-
term memory is normal (Korzus et al., 2004). During C. elegans
development, the block to cell differentiation that occurs in CBP
mutant embryos can be rescued by a wild-type transgene but not
by an AT-defective transgene (Victor et al., 2002), whereas a
CBP allele with enhanced AT activity antagonizes activated Ras
in vulval induction (Eastburn and Han, 2005). Drosophila CBP
(dCBP) AT activity is required for activation of wingless
expression in Drosophila embryos (Ludlam et al., 2002), and
for a rough eye over-expression phenotype (Kumar et al., 2004).
Together, these results indicate that the AT activity is essential
for many processes in vivo, but the response of very few CBP
target genes have been examined. Interestingly, induction of
bone morphogenetic protein (BMP)-target genes in mouse
embryonic stem (ES) cells is absent in a p300 null knock-out but
occurs efficiently in a p300 AT-defective knock-in (Shikama et
al., 2003), showing that some BMP-target genes are regulated
by p300 in an AT-independent manner. In this study, we show
that in Drosophila embryos, CBP-regulated genes in the Dpp
pathway appear to be controlled independently of CBP AT
activity as well.
In Drosophila, dCBP is necessary for proper embryo
development where it has been implicated in Hedgehog and
Wingless signaling, as well as in dorsal–ventral patterning
(Goodman and Smolik, 2000). Dorsal–ventral patterning is
initiated by the transcription factor Dorsal that can function
either as an activator or a repressor depending on the context of
its binding site on the DNA (Stathopoulos and Levine, 2002).
The Dpp gene, which encodes a TGF-β molecule, is repressed
by Dorsal in ventral parts of the embryo and the protein is
consequently present on the dorsal side. A gradient of Dpp
activity over the dorsal half of the embryo is formed via
diffusion of Dpp protein, as well as through binding of
inhibitory ligand traps Short-gastrulation (Sog) and Twisted-
gastrulation (Tsg) to Dpp, and subsequent cleavage of the ligand
traps by the Tolloid (Tld) protease. Dpp and the related TGF-β
molecule Screw (Scw) signal through the serine/threonine
kinase receptors Thickveins and Punt, which leads to
phosphorylation of the Smad molecule Mad that can then
interact with the Co-Smad Medea to regulate expression of
downstream genes (Raftery and Sutherland, 1999, 2003).
It has previously been demonstrated that a major cause of the
patterning defects seen in dCBP mutant Drosophila embryos is
impaired TGF-β signaling (Ashe et al., 2000; Lilja et al., 2003;
Waltzer and Bienz, 1999). We have shown that the main effect
of dCBP on the Dpp/Scw pathway in early embryos is on
expression of the Tld protease and the ligand Scw. Thereduction in the expression of these two genes prevents
activation of Dpp/Scw receptors, with consequent defects in
downstream target genes such as rhomboid (Lilja et al., 2003).
dCBP may also regulate Dpp/Scw-downstream genes through a
direct dCBP-Mad interaction (Waltzer and Bienz, 1999). In this
study, we wanted to investigate if different functions in dCBP
are used on separate promoters, e.g. those upstream versus
downstream of Dpp/Scw signaling. We found that a mutant
dCBP transgene rescues expression of an upstream but not a
downstream Dpp/Scw-target gene, and that a dCBP AT-




We affinity purified a guinea-pig anti-dCBP serum (Lilja et al., 2003) by
coupling 2 mg GST or GST-dCBP 1–178 to 1 ml Affi-gel 15 (Bio-Rad). The
serumwas diluted 1:3 with 10 mMTris pH 7.5 and passed over the GSTcolumn.
The flow-through was collected and applied to the GST-dCBP antigen column.
The column was washed with 10 mM Tris pH 7.5 and specific antibody eluted
with 4 M MgCl2, 0.25 M glycine pH 3.5, 0.1% Tween followed by 0.1 M
glycine pH 2.3, 0.1% Tween 20. Fractions were collected in 2 M Tris pH 7.9,
checked on SDS–PAGE and pooled.
ChIP assays were performed using a modification of previously published
methods (Cavalli et al., 1999; Frank et al., 2001). In brief, Drosophila embryos,
2–4 h old, were collected, dechorionated, and fixed in fixing solution (1xPBS
containing 2% paraformaldehyde) with an equal volume of n-heptane by
vigorous shaking for 25 min at room temperature. Fixed embryos were washed
twice with methanol and once with storage buffer (50 mM Tris–HCl pH 8.0,
1 mM EDTA), and kept at −80 °C until use. The following procedures were
performed at 4 °C. Approximately 100 μl of fixed embryos was lysed in 1 ml of
SDS–Lysis buffer (50 mMTris pH 8.1, 0.5% SDS, 100 mMNaCl, 5 mMEDTA,
and protease inhibitor cocktail) for 10 min and pelleted by centrifugation.
Embryos were resuspended in 1 ml of IP buffer (100 mM Tris pH 8.6, 0.3%
SDS, 1.7% Triton X-100, and 5 mM EDTA) and were then disrupted by
sonication twelve times for 12 s with a Branson 250 sonicator, at a power setting
of 4% and 30% duty cycle, yielding genomic DNA fragments with a bulk size of
300–600 bp. For each immunoprecipitation, supernatant (1.1 ml) containing
sheared chromatin was incubated with 22 μg of normal IgG (guinea pig) and
50 μl of 50% slurry of protein A agarose coated with salmon sperm DNA
(Upstate) for overnight to remove non-specific background. The precleared
chromatin was treated with 3 μg of affinity purified anti-dCBP antibody or 3 μg
of normal guinea pig IgG overnight, and formed immune complexes precipitated
with 50 μl of protein A agarose (50% slurry). The precipitated chromatin was
eluted and the cross-links reversed. DNA was purified by phenol/chloroform
extraction, ethanol-precipitated, and resuspended in 100 μl of water. For each
PCR reaction, 5 μl of DNA solution was used in a 40-μl reaction mixture. Whole
cell extract (WCE) corresponds to 2.7% of input. The sequence of the primers
for the 5′ end of the tld enhancer are: 5′-TGGAGTGCATTTCCTTAGGC + 5′-
TCCATCTATACGTGTACGCG, for the 3′ end of the enhancer: 5′-
ACCTGATCCTGGGCAAATGC + 5′-ATGGGCATAAGGCGCATTCC, and
for the coding region of tld: 5′-CCCAACTATCCGGAGGATTATCC + 5′-
TCCGAGTACTCGATCTCGAAGTG. The ChIP assay has been repeated
several times with equivalent results using embryos fixed on different occasions.
P-element construction and transformation
The F2161A point mutation was induced in the dCBP cDNA by
oligonucleotide mediated site directed mutagenesis (QuickChange mutagenesis
kit, Stratagene). A 1.64-kb AccI fragment in the dCBP cDNA was substituted
with a corresponding F2161 containing AccI fragment to ensure that no other
mutations were introduced by the mutagenesis procedure. The sequence of the
AccI fragment was confirmed by DNA sequencing. The Δ2546–2676 deletion
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followed by ligation of an EcoRI linker. The DNAwas then cleaved by EcoRI,
which also cuts at amino acid 2676 and at a site downstream of the cDNA
sequence. The two large fragments were religated without the DNA fragment
corresponding to amino acid 2546–2676. DNA sequencing was performed to
ensure that the deletion was in frame.
The dCBP cDNA and its mutant derivatives were cloned as a NotI fragments
into the pCaSpeR-hs P-element vector (Thummel and Pirrotta, 1992) to generate
hs-dCBP plasmids. The constructs were injected into w flies following standard
procedures (Rubin and Spradling, 1982). Three independent hs-dCBP, six hs-
dCBP F2161A, and two Δ2546–2676 transgenic lines were used in our
experiments and gave very similar results. In addition, we constructed
transgenes containing the dCBP cDNAs under control of the maternal hsp 83
promoter by cloning hsp 83-dCBP cDNA fragments into a pCaSpeR vector with
the SV40 polyA sequence. However, the transgenes derived from these
constructs could not rescue the dCBP phenotypes in our assays.
Fly strains and germ line clones
The dCBP allele nejire1 (nej1) was used in this study. It is a hypomorph
derived from a P-element insertion in the dCBP gene and causes a slight
reduction in dCBP levels (Akimaru et al., 1997; Lilja et al., 2003). nej1 FRT/
FM7c; hs-dCBP stocks were generated and used to create dCBP mutant
embryos derived from germ line clones by the FLP-FRT method (Chou and
Perrimon, 1996). nej1 FRT/FM7c; hs-dCBP females were crossed to ovoD
FRT/Y; hs-FLP males. Progeny from this cross were heat-shocked at 37 °C for
3 h on days 3, 4, and 5 after egglaying. The resulting nej1 FRT/ovoD FRT;
hs-dCBP/+ females were crossed to wild-type males and heat-shocked at 37 °C
for 45 min in an incubator before embryos were collected on apple juice plates.
Control nej1 FRT/ovoD FRT and wild-type w1118 flies were heat-shocked in
parallel before embryo collection.
In Figs. 5I and J, the nej1 FRT/ovoD FRT; hs-dCBP/+ females were crossed
to FM7/Y; hs-dCBP/+ males and heat-shocked at 37 °C for 45 min. They were
then allowed to lay embryos on apple juice agar plates for 2 h at 25 °C. The
embryos were aged at 18 °C and 25 °C to allow two collections per day until
they were 4–6 h old. The embryos were then washed into baskets and heat-
shocked in a water bath at 37 °C for 30 min. The embryos were aged another 5 h
and then fixed. The flies were heat-shocked again in the afternoon, and embryos
collected at room temperature overnight. These embryos were fixed in the
morning and used to determine kni expression in the absence of embryo heat-
shock (Figs. 5G and H).
In situ hybridisation and immunohistochemistry
RNA in situ hybridization using digoxigenin-labeled antisense RNA probes
was performed as previously described (Jiang et al., 1991; Tautz and Pfeifle,
1989). Immunohistochemistry using the tracheal lumen-specific antibody
mAb2A12 was performed essentially as described earlier (Samakovlis et al.,
1996). Embryos were fixed in 4% formaldehyde and devitellinized in methanol.
They were then rehydrated and incubated in PBSBT (1× PBS, 0.1% Triton X-
100, and 0.5% BSA) for 1.5 h at room temperature. The mouse IgM mAb2A12
(1:5 dilution) was added and incubated at 4 °C over night. Embryos were
washed in PBSBT and the primary antibody detected using the Vectastain ABC
Elite kit. The embryos were mounted in Permount (Fischer Scientific).
Microscopic slides with stained embryos were coded and embryos classified
according to their phenotype blindly. The resulting phenotypic ratios were tested
whether they differed significantly between nej1 mutants and nej1 mutants
carrying dCBP transgenes using pairwise χ2 tests. The same representative
transgenic line for each construct is shown in Figs. 3–5. Very similar results
were obtained in independent collections of germline clone embryos of the
different genotypes.
Western blotting
Embryo extracts were generated by grinding approximately 15 μl 2–4 h old
embryos in 100 μl SDS–sample buffer (280 mM Tris pH 6.8, 45% glycerol, 9%
SDS, 2.5% 2-mercaptoethanol), heating to 100 °C for 5 min, vortexing, and
centrifuging at 15,000 rpm for 5 min. The protein concentration of thesupernatant was determined by the Bio-Rad Protein Assay kit (Bio-Rad
Laboratories). Approximately 7 μg was loaded per lane on a 5% SDS–PAGE
gel. The proteins were transferred to PVDF membrane (Hybond-P, GE
Healthcare) in blotting buffer (25 mM Tris pH 8.3, 192 mM glycine, 0.1%
SDS, 20% methanol) at 100 V for 1 h. The membrane was washed in water,
soaked in methanol, and allowed to dry completely after transfer. It was blocked
in TBST (20 mM Tris pH 7.5, 139 mM NaCl, 0.1% Tween 20) containing 10%
non-fat dry milk and incubated with the affinity-purified dCBP serum (1:100 in
TBST) for 2 h. The membrane was washed with TBST and incubated for 2 h
with HRP-coupled anti-guinea pig antibody (1:100,000, Jackson), followed by
ECL detection (GE Healthcare), and exposure to a Luminescent Image Analyzer
(LAS-1000plus, Fujifilm). The membrane was re-probed with a mouse
monoclonal anti-Hsp70 antibody (1:5000, clone BRM-22, Sigma) and HRP-
coupled anti-mouse antibody (1:5000, DAKO) to ensure equal loading.
HAT assay
The HATactivity of dCBPwas assayed as previously described (Bannister and
Kouzarides, 1996; Horiuchi and Fujimoto, 1975; Waltzer and Bienz, 1998). GST,
GST-dCBP 1675–2510, and GST-dCBP 1675–2510 F2161A fusion proteins
were expressed in BL21 cells and purified on glutathione-sepharose beads. Crude
core histones (25 μg) were incubated with 1 μg of GST or GST-fusion protein
together with 125 nCi 3H-acetyl-CoA at 30 °C for 20 min. The reaction was then
spotted on a phospho-cellulose P-81 disc that was incubated in 50 mMNaHCO3–
Na2CO3 buffer pH 9.2 for 30 min. The disc was washed in acetone followed by
methanol-chloroform (1:2), and then left to dry before scintillation counting.
GST pull-down assay
The GST-Mad MH2 expression plasmid was a kind gift from Lucas Waltzer
(CNRS, Toulouse, France) and is described in (Waltzer and Bienz, 1999). GST-
Med MH2 was generated by cloning a EcoRI–XbaI fragment from the Medea
cDNA (corresponding to amino acids 510–771) into the EcoRI and XbaI sites
of a modified pGEX-5X-3 vector. The fusion proteins were expressed in
Escherichia coli BL21 cells and purified on glutathione-sepharose beads.
Nucleotides 6963–9984 of wild-type and the Δ2546–2676 dCBP cDNA
were amplified by PCR (Expand High Fidelity enzyme, Roche) with an XhoI
site, a Kozak sequence, and an ATG added to the upstream primer, and an XbaI
site added to the downstream primer. The PCR products, containing amino acids
2232-end (3190), were cloned into XhoI/XbaI digested pBluescript.
The dCBP cDNAs were in vitro translated with the TNT T7-coupled
reticulocyte lysate system (Promega) in the presence of in vitro translation grade
35S-methionine (GE Healthcare). In vitro translated dCBP protein (15ul) was
precleared against glutathione-sepharose beads, mixed with equal amounts of
purified GST, GST-Mad MH2, or GST-Med MH2 protein on glutathione
sepharose beads, and incubated at room temperature for 1 h. The beads were
washed three times in NTEN buffer (20 mM Tris pH 8.0, 100 mM NaCl, 1 mM
EDTA, 0.5% NP40). Proteins bound to the beads were eluted by addition of
SDS–PAGE sample buffer and analyzed by SDS–polyacrylamide gel electro-
phoresis followed by exposure to an FLA 3000 Phosphorimager (Fuji).Results
Tolloid (tld) is a direct dCBP target gene
In embryos derived from females containing germline clones
of the dCBP allele nej1, Dpp/Scw signaling is impaired due to a
small decrease in dCBP concentration (Ashe et al., 2000; Lilja
et al., 2003; Waltzer and Bienz, 1999), while most other
patterning genes are expressed normally. We showed previously
that expression of the gene encoding the Tld protease as well as
an 800-bp tld enhancer-lacZ reporter gene is severely reduced
in embryos derived from nej1 germline clones (Lilja et al.,
2003). To examine if tld expression is directly regulated by
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embryo extract with an affinity purified dCBP antibody. We
found that both the 5′ and 3′ ends of the tld enhancer are
precipitated more efficiently by the dCBP antibody than by
control IgG, whereas the coding region of tld is not enriched by
the dCBP antibody (Fig. 1). We conclude that tld is directly
regulated by dCBP.
Rescue of tld and rhomboid (rho) gene expression by wild-type
and mutant dCBP transgenes
The AT activity of CBP has been shown to depend on the
evolutionarily conserved HAT domain and the Acetyl-CoA
binding motif, where point mutations of conserved amino acids
can abolish HAT activity (Ludlam et al., 2002; Martinez-Balbas
et al., 1998). We generated an F2161Amutant dCBP protein and
expressed the HAT-domain as a GST-fusion protein in bacteria.
As shown in Fig. 2B and reported previously (Ludlam et al.,
2002; Martinez-Balbas et al., 1998), the GST-dCBP F2161A
protein has lost its HAT activity, whereas the corresponding
wild-type protein efficiently acetylates histones. We generated
an F2161A mutant dCBP transgene that we compared to a wild-
type transgene.
We created another hs-dCBP transgene in which amino acids
2546–2676 are deleted. This region lies outside of the HAT-
domain and is part of a region (2413–2608) previously shown
to physically interact with Mad (Waltzer and Bienz, 1999). We
confirmed that the C-terminus of dCBP binds to the Mad MH2
domain but could not detect an interaction with the Medea MH2
region in vitro (Fig. 2C). Surprisingly, the in vitro binding of
dCBP to Mad was not disrupted by the Δ2546–2676 deletion
(Fig. 2C). Despite this in vitro result, amino acids 2546–2676
are required for efficient rescue of some dCBP-regulated gene
expression phenotypes (see below).
In order to compensate for the reduction in maternally
produced endogenous dCBP in nej1 mutant embryos, we
introduced transgenes expressing dCBP in the germline underFig. 1. Drosophila CBP binds to the tolloid (tld) enhancer. Chromatin from
Drosophila embryo extract was immunoprecipitated with control IgG and
with affinity-purified dCBP serum. Associated DNA was assayed by PCR and
compared to DNA in whole-cell extract (WCE). dCBP binds to both the 5′ and
3′ ends of the 730 bp tld enhancer, but not to the tld coding region.
Fig. 2. The histone acetyltransferase activity of dCBP requires amino acid 2161.
(A) Schematic outline of dCBP indicating functional domains. The mutations
present in the F2161A and the Δ2546–2676 transgenes used in this study are
indicated. (B) The F2161A mutation abolishes HAT activity of a GST-dCBP
HAT-domain fusion protein. GST, GST-dCBP 1675–2510, and GST-dCBP
1675–2510 F2161A proteins purified from bacteria were incubated with crude
core histones and 3H-acetyl-CoA. Scintillation counts per minute are plotted as a
readout of incorporation of 3H-acetyl groups. (C) The Δ2546–2676 deletion
does not disrupt binding of dCBP to Mad in vitro. Bacterially produced GST,
GST-Mad MH2, and GST-Medea MH2 proteins were incubated with in vitro
translated C-terminus of dCBP or dCBP with the Δ25246–2676 deletion. GST-
Mad binds efficiently to both wild-type and mutant dCBP protein. (D) A
Western blot of embryo extracts prepared from wild-type (wt), nej1 germline
clones, nej1 germline clones with wild-type, F2161A, or Δ2546–2676 mutated
dCBP transgenes was probed with affinity-purified dCBP serum, and re-probed
with a monoclonal Hsp70 antibody to ensure equal loading.
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nej1 germline clones as well as hs-dCBP transgenes were heat-
shocked to induce transgene expression and embryos were
collected and processed for in situ hybridization. Embryos from
heat-shocked wild-type flies and from heat-shocked females
containing nej1 germline clones but lacking hs-dCBP trans-
genes served as controls.
The mRNA for the tld protease is present in dorsal cells of pre-
gastrulating embryos (Fig. 3C). Expression of tld is severely
reduced in 39% of nej1 mutant embryos except for an anterior
cap, which might be controlled separately (Fig. 3A). As shown in
Fig. 3B, in 9% of nej1 mutant embryos the tld expression pattern
is intermediate between a wild-type and a fully mutant pattern. In
embryos derived from nej1 germline clone females expressing a
wild-type dCBP transgene, a significant portion regain full
expression of tld (Figs. 3D and E). Interestingly, a similar rescue
was obtained in embryos that acquired the dCBP F2161A or
dCBPΔ2546–2676 transgene (Figs. 3D and E), implying that
neither the acetyltransferase activity of dCBP, nor amino acids
2546–2676, are necessary for regulation of the tld gene. A
Western blot showed that embryos with the F2161A or Δ2546–
2676 transgenes did not express higher levels of dCBP than
embryos with wild-type transgene (Fig. 2D). Furthermore, similar
results were obtained with six independent F2161A and two
Δ2546–2676 transgenic lines, indicating that rescue with mutant
dCBP to wild-type levels is independent of position effects.
The rho gene is expressed in two ventrolateral stripes under
control of the Dorsal transcription factor, as well as in the dorsal
part of the embryo where it is activated by the Smad proteinsFig. 3. Rescue of tld and early rho expression in dCBP mutant embryos receiving hs-
RNA probes. dCBPmutant embryos were derived from nej1 germline clones and were
was induced in the mother prior to egg deposition. (A–C) Representative cellularizin
left illustrating the range of phenotypes present in nej1 mutant embryos. (F–H) Repre
the nej1mutant embryos are shown. Cellularized stage 5 embryos are oriented with do
expression pattern. (D, I) A graphic representation of the distribution of tld (D) and
(nej1), as well as in nej1 mutants carrying insertions of hs-dCBP wild-type, F216
significant difference between the phenotype of nej1 mutants and nej1 mutants
Acetyltransferase (AT)-defective (F2161A) and Δ2546–2676-deleted transgenes resMad and Medea in response to Dpp/Scw signaling (Fig. 3H,
arrow). We showed previously that the lack of tld expression in
nej1 mutant embryos results in an inability of Dpp and Scw to
activate its receptors on the receiving cells, presumably because
they are sequestered by the ligand traps Sog and Tsg (Lilja et al.,
2003). As a consequence, the Dpp/Scw-dependent pattern of
rho expression is absent except for an anterior cap (Fig. 3F,
arrow). In 46% of stage 5 nej1 mutant embryos, the dorsal rho
pattern is missing (Figs. 3F, I, and J). The fraction of embryos
showing this phenotype can be diminished by expression of a
wild-type hs-dCBP transgene in the germline (Figs. 3I and J).
Similarly, when nej1 mutant embryos receive F2161A or
Δ2546–2676 mutant dCBP protein, rho expression is rescued
to an extent comparable to wild-type dCBP (Figs. 3I and J).
In embryos that have gastrulated, Dpp/Scw signaling
recovers in some nej1 mutant embryos without a restoration of
rho expression (Lilja et al., 2003). It is possible therefore that
rho expression is also controlled by dCBP independently of its
role in tld expression, probably through a direct dCBP-Mad
interaction (Waltzer and Bienz, 1999). We scored the dorsal rho
expression pattern as wild-type ormutant in stages 6–8 embryos.
Reduced rho expression was found in 26% of nej1 mutant
embryos, which could be rescued to 14% by the wild-type dCBP
transgene (Fig. 4). A similar rescue (12% mutant embryos) was
obtained with the F2161A mutant transgene (Figs. 4C and D).
By contrast, rho expression in post-gastrula embryos cannot be
rescued by the Δ2546–2676 transgene (Figs. 4C and D). This
indicates that amino acids 2546–2676 in dCBP are necessary for
activation of Dpp/Scw-target genes.dCBP transgenes. Embryos were hybridized with digoxigenin-labeled antisense
rescued with heat-shock induced dCBP transgenes (hs-dCBP) whose expression
g embryos hybridized with a tld probe oriented with dorsal up and anterior to the
sentative embryos illustrating the range of rho expression phenotypes present in
rsal up and anterior to the left. Arrows point to the Dpp-dependent part of the rho
rho (I) expression phenotypes in wild-type embryos, in dCBP mutant embryos
1A, or Δ2546–2676-deleted transgenes. Double asterisk indicates statistically
with dCBP transgene, p<0.01. (E, J) Table of the data in panels D and I.
cue tld and early rho expression to a similar extent as the wild-type transgene.
Fig. 4. Expression of rho in post-gastrula dCBP mutant embryos. Mutant
embryos were derived from nej1 germline clones and were rescued with hs-
dCBP transgenes expressed in the germline. The embryos were hybridized with
a digoxigenin-labeled rho antisense RNA probe. (A, B) Representative stage 6
embryos illustrating the rho expression patterns in nej1 mutant embryos are
shown. Dorsal is up, anterior to the left, and the Dpp-dependent rho pattern is
indicated by arrows. (C) Graph illustrating the distribution of phenotypes of rho
expression in wild-type, in dCBP mutant (nej1), as well as in nej1 mutant
embryos carrying hs-dCBP transgenes. Asterisk indicates statistically significant
difference between the phenotype of nej1 mutants and nej1 mutants with dCBP
transgene, p<0.05. (D) Table of distributions presented in panel C. Wild-type
and AT-defective transgenes rescue rho expression similarly, whereas the
Δ2546–2676-deleted transgene fails to rescue.
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requires dCBP AT activity, control of Dpp/Scw signaling by
dCBP in early embryos may occur independently of histone and
other protein acetylation.
Dorsal branch formation in the trachea requires amino acids
2546–2676 in dCBP
At later stages of embryo development, the reduced levels
of dCBP obtained in nej1 germ line clones causes additional
phenotypes. As noted previously (Waltzer and Bienz, 1999),
one consistent phenotype in nej1 mutant embryos is a failure
to form some of the tracheal dorsal branches (Fig. 5A,
compare with Fig. 5B). As shown in Figs. 5C and D, 37% of
embryos that are morphologically unaffected specifically lack
at least one tracheal dorsal branch. In embryos receiving wild-
type dCBP from an hs-dCBP transgene expressed in the
mother, the percentage of mutant embryos is reduced to 14%
(Figs. 5C and D). However, this phenotype is only weakly
rescued in embryos receiving dCBP F2161A or dCBPΔ2546–
2676 (Figs. 5C and D).
Dpp signaling is required for dorsal branch formation and
induces expression of the related transcription factors Knirps(Kni) and Knirps-related (Knrl) in tracheal cells (Chen et al.,
1998; Llimargas and Casanova, 1997; Vincent et al., 1997;
Wappner et al., 1997). We examined kni expression in embryos
derived from nej1 germline clones and found reduced kni
expression in cells of the dorsal branches in 44% of the embryos
(Figs. 5E, G, and H). This phenotype was rescued to 26%
mutant embryos by expression of wild-type dCBP in the
mother. By contrast, 42% and 39% of embryos receiving the
dCBP F2161A or dCBPΔ2546–2676 transgenes, respectively,
display a mutant kni expression pattern.
Since rescue of the trachea phenotype is achieved many
hours after induction of dCBP transgene expression, it is
possible that the mutant transgenes fail to rescue because the
encoded mutant proteins are less stable than wild-type dCBP.
We therefore induced transgene expression both in the mother
and in 4- to 6-h-old embryos. At the time of fixation, the
embryos had not developed for a longer time after heat-shock
than that of early embryos after transgene induction in the
mother, where wild-type and mutant proteins behaved
similarly. Since both parents were heterozygous for the
transgene, 75% of the embryos will express it zygotically.
Therefore, if reduced protein stability is causing the failure to
rescue the kni expression phenotype, we would expect to
improve the ability of mutant transgenes to rescue after
embryo heat-shock compared to heat-shock only in the
mother. We observed the kni expression phenotype in 39%
of nej1 embryos after heat-shock in both mother and embryo,
compared to 23% for embryos that received the wild-type
dCBP transgene (Figs. 5I and J). These numbers are similar to
those observed when only the mothers are heat-shocked (Figs.
5G and H). For the dCBP F2161A genotype, we do find
slightly better rescue after embryo heat-shock (32% compared
to 39% in nej1 mutants versus 42% compared to 44% in nej1
mutants when heat-shock was applied only in mothers; Figs.
5G–J). We interpret this to mean that F2161A mutant dCBP
protein might be less stable than the wild-type protein, and
that it can partly rescue the kni expression phenotype when
present at sufficient levels. However, the Δ2546–2676 mutant
protein fails to rescue the tracheal kni expression even after
heat-shock induction in the embryo (Figs. 5I and J, compare to
G and H).
Taken together, our results indicate that residues 2546–2676
are part of a region in dCBP that is necessary for tracheal branch
formation and Dpp-target gene expression but is not essential
for regulation of tld and rho gene expression in early embryos.
Discussion
CBP has been implicated in numerous pathways in both
mammals and in Drosophila and seems to affect the activity
of a large number of transcription factors, either through
protein–protein interactions or through acetylation of histones
or other transcription factors (Goodman and Smolik, 2000;
Kalkhoven, 2004). During early Drosophila embryogenesis,
Dpp/Scw signaling is particularly sensitive to the small
decline in dCBP levels obtained in embryos derived from
nej1 germline clones. In order to distinguish the AT activity of
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introduced a wild-type, AT-defective F2161A, and a Δ2546–
2676 dCBP transgene into nej1 mutant embryos, with the aim
of rescuing some of the phenotypes in embryo development
caused by this mutation.
We established that the tld gene is directly regulated by
dCBP, and that rescue of its transcription defect in nej1 mutant
embryos does not require the AT activity in dCBP. Since a
substantial amount of endogenous dCBP protein remains in
nej1 mutant embryos (Fig. 2D), we cannot exclude that AT-
defective dCBP protein cooperates with AT-proficient endo-
genous dCBP, masking a need for the AT activity. However,
there is to date no evidence that CBP proteins form dimers. For
this reason, we favor the idea that the AT function in dCBP is
dispensable for tld expression. Dpp/Scw-target genes are likely
directly regulated by dCBP as well since the enhancer of one
target, Race, can be immunoprecipitated by the dCBP antibody
(data not shown). The AT activity of dCBP is dispensable for
expression of Dpp/Scw-targets genes too. Intriguingly, a similar
result was obtained in mouse ES cells, where BMP2 and BMP4-
target gene expression was as efficient or even more efficient in
cells with an AT-defective p300 knock-in than in wild-type
cells, whereas p300 null cells failed to induce BMP-target genes
(Shikama et al., 2003). Since Dpp and BMP proteins are
homologous TGF-β molecules, these results taken together
suggest that CBP might be using a mechanism not dependent on
acetylation to regulate some TGF-β signaling pathways in both
mouse and fly. This mechanism may involve interactions with
the basal transcription machinery (Kwok et al., 1994; Nakajima
et al., 1997a,b), whereby CBP would act to bridge enhancer-
binding factors to the basal promoter region.
It has previously been shown that formation of dorsal
branches in the tracheal airway system of Drosophila embryos
is sensitive to dCBP mutations (Waltzer and Bienz, 1999). Since
dorsal branch formation relies on Dpp signaling (Llimargas andFig. 5. Formation of dorsal branches in the trachea requires amino acids 2546–
2676. Mutant embryos were derived from nej1 germline clones and were
rescued with hs-dCBP transgenes whose expression was induced in the mother
(C–H) or in mother and embryo (I, J). In panels A–D, the tracheal lumen of
wild-type and dCBP mutant embryos was stained with the 2A12 monoclonal
antibody. Stage 15 embryos are oriented with dorsal up and anterior to the left.
(A) Picture of a representative nej1 mutant embryo lacking two of the dorsal
tracheal branches (arrowheads). One to two dorsal branches were missing in the
majority of nej1 mutant embryos with normal morphology but displaying a
tracheal phenotype. Morphologically abnormal embryos were excluded from the
analysis. (B) A wild-type embryo is shown. (E–J) Expression of kni in dorsal
branch cells of the trachea is affected in nej1 mutant embryos. Stage 13 embryos
oriented with dorsal up and anterior to the left are shown after hybridization of a
kni probe. (E) A representative nej1 mutant embryo lacking kni expression in
two dorsal branches (arrowheads). (F) A wild-type embryo is shown for
comparison. (C, G, I) A graphic representation of the dorsal branch phenotype in
wild-type, dCBP mutant (nej1), and nej1 mutant embryos with wild-type,
F2161A, or Δ2546–2676-deleted hs-dCBP transgenes induced in the mother
(C, G) or mother and embryo (I). A statistically significant difference between
the phenotype of nej1 mutants and nej1 mutants with dCBP transgene is
indicated by a single asterisk (p<0.05) or a double asterisk (p<0.01). (D, H, J)
Table of the data in panels C, G, and I. The AT-defective (F2161A) transgene can
partly rescue after heat-shock induction in the embryo, whereas the Δ2546–
2676-deleted transgene is unable to rescue the trachea phenotype to the same
extent as the wild-type transgene.
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was suggested that the dCBP tracheal phenotype could be caused
by a role for dCBP in Dpp signaling also in this process (Waltzer
and Bienz, 1999). This notion is supported by our finding of
reduced expression of the Dpp-target gene kni in embryos from
nej1 germline clones (Fig. 5). It remains to be determined whether
dCBP is acting cell-autonomously in the tracheal cells, or if it
regulates expression of components of the Dpp-pathway in
surrounding cells.
Our rescue experiments of the trachea phenotype showed
that the AT-defective dCBP transgene was only partly able to
rescue dorsal branch formation compared to the wild-type
transgene, even after taking into account the 25% of embryos
that lack zygotic expression (Figs. 5I–J, and data not shown).
This result suggests that acetylation of histones or other proteins
by dCBP might contribute to the migration of these tracheal
cells towards Dpp secreting cells. Alternatively, the level of
expression of the mutant forms of dCBP may not be comparable
to the wild-type dCBP, resulting in a less efficient rescue of the
tracheal phenotype.
Deletion of amino acids 2546–2676 in dCBP has no
consequence for rescue of tld and rho expression in early
embryos, but fails to efficiently rescue Dpp/Scw-target gene
expression in newly gastrulated embryos as well as tracheal
dorsal branch formation. This deletion was constructed with
the aim of disrupting Mad binding to dCBP. However, the
mutant protein is still able to interact with Mad in vitro. This
could be because the deletion does not entirely remove the
region (amino acids 2413–2608) that is sufficient for an
interaction with Mad, or because there are other parts of
dCBP that can interact with Mad as well. It is possible that
the deletion disrupts binding to other proteins that function in
activation of rho expression in response to Dpp/Scw
signaling, and in tracheal branch migration. Another
possibility is that although the binding to Mad is unaffected
in vitro, the dCBP–Mad interaction could be weakened in
vivo, which would make Mad unable to activate Dpp-target
genes. In either case, this part of dCBP is dispensable for tld
and rho expression in early embryos. This indicates that
different parts of dCBP are required on different promoters.
These results also support a function for dCBP both upstream
and downstream of Dpp/Scw signaling since a dCBP domain
that is not needed for tld and early rho expression is
required for rescue of Dpp/Scw-target gene expression after
gastrulation.
In summary, our data and the work of others show that
separate functions in CBP are used on different promoters, and
that the AT activity of CBP is important for some events in
development but is dispensable for certain aspects of BMP/Dpp
signaling (Shikama et al., 2003).
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